- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 594 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
| 25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 2 | RTTNews | ||
| 25.06. | Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? | 3 | Benzinga.com | ||
| 25.06. | Glucotrack reports positive results from first human trial of blood glucose monitor | 3 | Investing.com | ||
| 25.06. | Glucotrack berichtet über positive Ergebnisse der ersten klinischen Studie am Menschen | 2 | Investing.com Deutsch | ||
| 25.06. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology | 1 | MassDevice | ||
| 12.06. | Glucotrack announces 1-for-60 reverse stock split effective June 16 | 2 | Investing.com | ||
| 12.06. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.06. | GlucoTrack, Inc.: Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements | 233 | GlobeNewswire (Europe) | 1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the... ► Artikel lesen | |
| 04.06. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.06. | Glucotrack, Inc.: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions | 1 | GlobeNewswire (USA) | ||
| 28.05. | Glucotrack appoints new board member with diabetes tech expertise | 1 | Investing.com | ||
| 28.05. | Glucotrack, Inc.: Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD | 14 | GlobeNewswire (USA) | ||
| 20.05. | Glucotrack, Inc.: Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development | 1 | GlobeNewswire (USA) | ||
| 20.05. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.05. | Glucotrack GAAP EPS of -$0.67 | 1 | Seeking Alpha | ||
| 14.05. | Glucotrack, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | 416 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 13.05. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 66,40 | -0,60 % | Eckert&Ziegler mit BLITZMELDUNG: Könnte die Aktie am Montag komplett einbrechen - Experten empfehlen SOFORT zu handeln! | ||
| SERNOVA BIOTHERAPEUTICS | 0,096 | +0,52 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | SYNLAB AG: Zurückziehung - 01.07.2025 | ||
| NUGEN MEDICAL DEVICES | 0,036 | 0,00 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
| ATOSSA THERAPEUTICS | 0,715 | +2,00 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,956 | -1,65 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,115 | -4,95 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,238 | -0,83 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,917 | +3,38 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,501 | -2,15 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| QUIDELORTHO | 25,000 | -2,34 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 148,60 | -0,10 % | Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now? |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,090 (+1,36 %) liegt der Kurs bei 6,710 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.